相似文献
1
Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
Atherosclerosis. 1978 Mar;29(3):345-54. doi: 10.1016/0021-9150(78)90081-3.
2
Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
Int J Clin Pharmacol Biopharm. 1977 Apr;15(4):166-71.
3
A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
Atherosclerosis. 1972 Jul-Aug;16(1):9-14. doi: 10.1016/0021-9150(72)90003-2.
4
[Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].
Dtsch Med Wochenschr. 1973 Dec 7;98(49):2328-33. doi: 10.1055/s-0028-1107251.
5
Comparative study of several hypolipidemic agents related to clofibrate.
Atherosclerosis. 1974 Sep-Oct;20(2):141-53. doi: 10.1016/0021-9150(74)90001-x.
6
Dose-response to tibric acid: a new hypolipidemic drug in type IV hyperlipoproteinemia.
Clin Pharmacol Ther. 1975 May;17(5):606-11. doi: 10.1002/cpt1975175606.
7
The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug.
Atherosclerosis. 1979 Feb;32(2):155-63. doi: 10.1016/0021-9150(79)90080-7.
8
Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
JAMA. 1984 May 4;251(17):2241-6. doi: 10.1001/jama.1984.03340410049031.
9
Editorial: Lipid-lowering drugs after myocardial infarction.
Lancet. 1975 Mar 1;1(7905):501-2.
10
[Treatment of hyperlipemia with tibric acid (TA)].
Minerva Med. 1978 Jun 2;69(28):1917-22.
Zotero 插件